← GLAUKOS Corp
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $4.5m | ($92k) | ($13.0m) | $15.4m | ($120.3m) | ($49.6m) | ($99.2m) | ($134.7m) | ($146.4m) | ($187.7m) | — | |
| Depreciation, Depletion and Amortization | $4.7m | $5.5m | $6.3m | $6.3m | $29.4m | $29.7m | $31.6m | $33.7m | $35.6m | $38.1m | $46.4m | |
| Depreciation | $4.7m | $5.5m | $6.3m | $6.3m | $29.4m | $29.7m | $6.7m | $8.7m | $10.9m | $11.0m | $16.0m | |
| Amortization of Debt Issuance Costs and Discounts | — | — | ($295k) | ($338k) | $6.0m | $1.4m | $1.4m | $1.4m | $718k | — | — | |
| Amortization of Intangible Assets | $3.7m | — | — | — | $24.9m | $24.9m | $24.9m | $24.9m | $24.7m | $27.1m | — | |
| Deferred Income Tax Expense (Benefit) | — | ($235k) | — | ($66.3m) | ($12.0m) | ($1.0m) | ($55k) | ($120k) | ($216k) | ($6.5m) | ($6.5m) | |
| Share-based Payment Arrangement, Noncash Expense | $8.8m | $17.6m | $25.7m | $36.4m | $46.5m | $30.1m | $38.6m | $43.5m | $50.2m | $63.2m | $80.2m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | $587k | $5.6m | $3.9m | $3.7m | $2.7m | $3.3m | $6.6m | $8.1m | — | |
| Share-based Payment Arrangement, Expense | $8.8m | $17.6m | $25.7m | $39.5m | $43.3m | $30.1m | $38.6m | $43.5m | $50.2m | $63.2m | $80.2m | |
| Goodwill, Impairment Loss | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $115.5m | |
| Impairment of Intangible Assets (Excluding Goodwill) | — | — | — | — | — | — | — | — | — | $112.9m | — | |
| Nonoperating Income (Expense) | $324k | $2.3m | $634k | $256k | ($8.8m) | ($16.4m) | ($16.1m) | ($5.0m) | ($23.2m) | $6.6m | — | |
| Other Nonoperating Income (Expense) | — | — | ($1.6m) | — | — | — | — | — | — | $479k | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | $6.8m | $2.2m | $2.3m | $6.6m | ($2.2m) | ($1.7m) | $3.1m | $3.8m | $22.0m | $53.0m | ($60.9m) | |
| Increase (Decrease) in Inventories | $2.9m | $4.2m | $2.3m | ($4.1m) | ($2.0m) | $7.7m | $15.5m | $4.8m | $18.8m | $7.7m | ($918k) | |
| Inventory Write-down | — | — | — | — | — | — | — | $0 | $4.4m | $2.6m | — | |
| Net Cash Provided by (Used in) Operating Activities | $12.3m |
$25.5m
+107.23%
|
$18.9m
-26.05%
|
($369k)
-101.96%
|
($23.0m)
-6129.81%
|
$24.7m
+207.48%
|
($33.1m)
-233.90%
|
($57.8m)
-74.59%
|
($61.3m)
-6.16%
|
($14.8m)
+75.88%
|
($950k)
+93.58%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $6.3m | $6.3m | $10.3m | $4.7m | $6.9m | $47.8m | $30.3m | $20.2m | $6.3m | $7.7m | ($27.9m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | ($40k) | ($6k) | ($156k) | ($430k) | ($367k) | ($7k) | $24k | ($893k) | ($598k) | ($32k) | ($3.2m) | |
| Cash, Cash Equivalents, and Short-term Investments | $95.8m | $119.0m | $149.3m | $183.3m | $413.9m | $423.5m | — | — | — | — | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | — | — | — | — | — | $12.4m | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($26.1m) | ($11.7m) | ($26.4m) | $43.4m | ($205.1m) | ($58.2m) | $44.8m | $14.1m | $47.8m | ($77.6m) | ($14.7m) | |
| Cash flows from financing activities: | ||||||||||||
| Induced Conversion of Convertible Debt Expense | — | — | — | — | — | — | — | — | $18.0m | — | — | |
| Net Cash Provided by (Used in) Financing Activities | ($1.6m) |
$4.7m
+384.23%
|
$21.6m
+362.31%
|
($9.6m)
-144.70%
|
$262.5m
+2822.05%
|
$39.3m
-85.05%
|
$6.3m
-84.08%
|
$15.0m
+140.63%
|
$91.5m
+508.56%
|
$11.9m
-87.02%
|
$24.5m
+105.71%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $371k | ($434k) | $14.1m | $33.2m | $34.4m | $4.0m | $16.5m | ($27.3m) | $75.0m | ($79.7m) | $113.5m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | ($15.1m) | $17.9m | $38.6m | $71.8m | $106.2m | $110.1m | $126.6m | $99.3m | $174.4m | $94.6m | $113.5m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $6.1m | $3.7m | $18.7m | $15.1m | $20.2m | $26.1m | $3.6m | $12.7m | $39.3m | $13.5m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $285k | — | — | $2k | $1.3m | $4.1m | $4.4m | $4.3m | $4.5m | $4.2m | — | |
| Income Taxes Paid, Net | $513k | $12k | $401k | $171k | $484k | $272k | $522k | $1.6m | $1.4m | $949k | — | |
| Additional Financial Items | ||||||||||||
| Foreign Currency Transaction Gain (Loss), before Tax | ($608k) | $100k | — | — | — | — | — | — | — | — | — | |
| Foreign Currency Transaction Gain (Loss), Unrealized | ($368k) | $951k | ($1.6m) | ($194k) | $1.2m | ($2.3m) | ($2.2m) | $980k | ($4.6m) | $1.2m | — | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | — | $30.0m | $30.0m | — | — | — | — | |
| Goodwill | — | — | — | $66.1m | $66.1m | $66.1m | $66.1m | $66.1m | $66.1m | $66.7m | $115.5m | |
| Income Tax Expense (Benefit) | $43k | $93k | $583k | ($65.5m) | ($12.0m) | $326k | $766k | $934k | $771k | ($5.4m) | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $10.0m | $4.6m | — | |
| Operating Expenses | $94.0m | $140.5m | $169.2m | $248.7m | $256.8m | $260.3m | $296.2m | $367.8m | $411.8m | $482.4m | — | |
| Operating Lease, Expense | — | — | — | $2.5m | — | — | — | — | — | — | — |